N4P — N4 Pharma Balance Sheet
0.000.00%
Last trade - 00:00- £4.79m
- £3.06m
- £0.01m
Annual balance sheet for N4 Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.56 | 1.78 | 1.92 | 1.03 | 0.626 |
| Net Total Receivables | 0.255 | 0.551 | 0.21 | 0.176 | 0.135 |
| Prepaid Expenses | |||||
| Total Current Assets | 3.83 | 2.34 | 2.17 | 1.21 | 0.776 |
| Net Goodwill | |||||
| Total Assets | 3.83 | 2.34 | 2.17 | 1.28 | 0.776 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.169 | 0.213 | 0.078 | 0.082 | 0.124 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.169 | 0.213 | 0.078 | 0.148 | 0.128 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.66 | 2.13 | 2.09 | 1.13 | 0.648 |
| Total Liabilities & Shareholders' Equity | 3.83 | 2.34 | 2.17 | 1.28 | 0.776 |
| Total Common Shares Outstanding |